Unidade Local de Saude de Matosinhos SA
About Unidade Local de Saude de Matosinhos SA
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
5
Amgen
4
Hoffmann-La Roche
3
Pharmacyclics LLC.
1
Shire
1
Zymeworks Inc.
1
Clinical Trials at Unidade Local de Saude de Matosinhos SA
During the past decade, Unidade Local de Saude de Matosinhos SA conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on
average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
2017-01-01
2026-06-01
Active, not recruiting
431
A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)
2018-01-24
2022-05-19
Completed
93
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
2019-09-30
2025-03-31
Recruiting
162
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
2018-08-27
2027-05-09
Active, not recruiting
713
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
2020-02-26
2027-01-14
Recruiting
162
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
2020-06-04
2026-04-27
Active, not recruiting
345
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.
2020-06-15
2022-02-18
Completed
1,808
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Unidade Local de Saude de Matosinhos SA" #1 sponsor was "Bayer" with 5 trials, followed by "Amgen" with 4 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pharmacyclics LLC." with 1 trials sponsored and "Shire"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Unidade Local de Saude de Matosinhos SA"
#1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Unidade Local de Saude de Matosinhos SA
According to Clinical.Site data, the most researched conditions in "Unidade Local de Saude de Matosinhos SA" are
"COVID-19" (2 trials), "Chemotherapy-induced Thrombocytopenia" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Atrial Fibrillation" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Unidade Local de Saude de Matosinhos SA" in a lesser frequency.
Clinical Trials Intervention Types at Unidade Local de Saude de Matosinhos SA
Most popular intervention types in "Unidade Local de Saude de Matosinhos SA" are "Drug" (12 trials), "Other" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Cisplatin" (2 trials), "Romiplostim" (2 trials), "5-Fluorouracil" (1 trials) and "AMG 510" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Unidade Local de Saude de Matosinhos SA
The vast majority of trials in "Unidade Local de Saude de Matosinhos SA" are
13 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Unidade Local de Saude de Matosinhos SA
Currently, there are NaN active trials in "Unidade Local de Saude de Matosinhos SA".
undefined are not yet recruiting,
5 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Unidade Local de Saude de Matosinhos SA,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Unidade Local de Saude de Matosinhos SA, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".